{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:34:45Z","timestamp":1765334085661,"version":"3.46.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108740","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:26:07Z","timestamp":1761121567000},"page":"108740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Comparative in silico analysis identifies potent natural and synthetic peptide candidates for targeting SARS-CoV-2 viral proteins"],"prefix":"10.1016","volume":"120","author":[{"given":"Sara","family":"Mortezaali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Ebrahimi","family":"Tarki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboobeh","family":"Zarrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2025.108740_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173664","article-title":"Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 mpro, using molecular docking and dynamics simulation studies","volume":"890","author":"Ahamad","year":"2021","journal-title":"Eur. J. Pharm."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108740_bib2","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ph15101283","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiolchem.2025.108740_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115860","article-title":"Protease targeted COVID-19 drug discovery and its challenges: insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors","volume":"29","author":"Amin","year":"2021","journal-title":"Bioorg. Med Chem."},{"unstructured":"An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination - PubMed [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/33226885\/\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib4"},{"unstructured":"Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery | Pharmacological Reports [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/link.springer.com\/article\/10.1007\/s43440-022-00432-6\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib5"},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108740_bib6","volume":"14","author":"Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study. Arabian Journal of Chemistry","year":"2021"},{"unstructured":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, (n.d) efficient optimization and multithreading - PMC [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3041641\/\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib7"},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108740_bib8","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1080\/07391102.2020.1766572","article-title":"Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors","volume":"39","author":"Bhardwaj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.compbiolchem.2025.108740_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/erv.09.160","article-title":"Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists","volume":"9","author":"Black","year":"2010","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.compbiolchem.2025.108740_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1288363","article-title":"Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2","volume":"14","author":"Dai","year":"2023","journal-title":"Front Pharm."},{"issue":"238","key":"10.1016\/j.compbiolchem.2025.108740_bib11","first-page":"614","article-title":"Pharmacological treatment for the management of COVID-19: a narrative review","volume":"59","author":"Dhakal","year":"2021","journal-title":"JNMA J. Nepal Med Assoc."},{"unstructured":"Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation | Scientific Reports [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/www.nature.com\/articles\/s41598-020-74099-5\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib12"},{"volume":"2","year":"2021","author":"Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2. Chemical Physics Impact","key":"10.1016\/j.compbiolchem.2025.108740_bib13"},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108740_bib14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s11030-020-10151-w","article-title":"Molecular docking studies, molecular dynamics and ADME\/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2","volume":"25","author":"Elekofehinti","year":"2021","journal-title":"Mol. Divers"},{"unstructured":"Frontiers | Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics [Internet]. [cited 2025a Jan 3]. Available from: \u3008https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/10.3389\/fphar.2021.731828\/full\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib15"},{"unstructured":"Frontiers | Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2 [Internet]. [cited 2025b Jan 3]. Available from: \u3008https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/10.3389\/fmicb.2021.647295\/full\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib16"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108740_bib17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"unstructured":"g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations | Journal of Chemical Information and Modeling [Internet]. [cited 2025 Jan 3]. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/ci500020m.","key":"10.1016\/j.compbiolchem.2025.108740_bib18"},{"key":"10.1016\/j.compbiolchem.2025.108740_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74060","article-title":"Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein","volume":"12","author":"Geng","year":"2023","journal-title":"eLife"},{"issue":"21","key":"10.1016\/j.compbiolchem.2025.108740_bib20","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: drug targets and potential treatments","volume":"63","author":"Gil","year":"2020","journal-title":"J. Med Chem."},{"issue":"7811","key":"10.1016\/j.compbiolchem.2025.108740_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiolchem.2025.108740_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107969","article-title":"Multifunctional inhibitors of SARS-CoV-2 by MM\/PBSA, essential dynamics, and molecular dynamic investigations","volume":"107","author":"Kumar","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108740_bib23","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1080\/07391102.2022.2071340","article-title":"Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA","volume":"41","author":"Kumari","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2025.108740_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2020.11.083","article-title":"Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors","volume":"538","author":"Li","year":"2021","journal-title":"Biochem Biophys. Res Commun."},{"issue":"23","key":"10.1016\/j.compbiolchem.2025.108740_bib25","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.3390\/molecules25235535","article-title":"In silico discovery of antimicrobial peptides as an alternative to control SARS-CoV-2","volume":"25","author":"Liscano","year":"2020","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108740_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103315","article-title":"Antiviral peptides against the main protease of SARS-CoV-2: a molecular docking and dynamics study","volume":"14","author":"Mahmud","year":"2021","journal-title":"Arab J. Chem."},{"issue":"9","key":"10.1016\/j.compbiolchem.2025.108740_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103315","article-title":"Antiviral peptides against the main protease of SARS-CoV-2: a molecular docking and dynamics study","volume":"14","author":"Mahmud","year":"2021","journal-title":"Arab. J. Chem."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108740_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jcc.21365","article-title":"A fast method for large-scale de novo peptide and miniprotein structure prediction","volume":"31","author":"Maupetit","year":"2010","journal-title":"J. Comput. Chem."},{"doi-asserted-by":"crossref","unstructured":"Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study. Informatics in Medicine Unlocked. 2020 Jan 1;19:100345.","key":"10.1016\/j.compbiolchem.2025.108740_bib29","DOI":"10.1016\/j.imu.2020.100345"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108740_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10989-021-10331-8","article-title":"In silico analysis of inhibiting Papain-like protease from SARS-CoV-2 by using Plant-Derived peptides","volume":"28","author":"Moradi","year":"2021","journal-title":"Int J. Pept. Res Ther."},{"issue":"16","key":"10.1016\/j.compbiolchem.2025.108740_bib31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.compbiolchem.2025.108740_bib32","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/cells9112343","article-title":"The SARS-CoV-2 spike glycoprotein as a drug and vaccine target: structural insights into its complexes with ACE2 and antibodies","volume":"9","author":"Papageorgiou","year":"2020","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.compbiolchem.2025.108740_bib33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"D1","key":"10.1016\/j.compbiolchem.2025.108740_bib34","doi-asserted-by":"crossref","first-page":"D288","DOI":"10.1093\/nar\/gkaa991","article-title":"DBAASP v3: database of antimicrobial\/cytotoxic activity and structure of peptides as a resource for development of new therapeutics","volume":"49","author":"Pirtskhalava","year":"2021","journal-title":"Nucleic Acids Res."},{"unstructured":"Potential SARS-CoV-2 Spike Protein-ACE2 Interface Inhibitors: Repurposing FDA-approved Drugs [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/www.xiahepublishing.com\/2572-5505\/JERP-2021-00050\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib35"},{"key":"10.1016\/j.compbiolchem.2025.108740_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608401","article-title":"Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors","volume":"16","author":"Puig","year":"2025","journal-title":"Front Immunol."},{"unstructured":"RCSB PDB: Homepage [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/www.rcsb.org\/\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib37"},{"key":"10.1016\/j.compbiolchem.2025.108740_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.addr.2020.11.007","article-title":"Peptide and peptide-based inhibitors of SARS-CoV-2 entry","volume":"167","author":"Sch\u00fctz","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"unstructured":"Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies - PubMed [Internet]. [cited 2025 Jan 3]. Available from: \u3008https:\/\/pubmed.ncbi.nlm.nih.gov\/33131721\/\u3009.","key":"10.1016\/j.compbiolchem.2025.108740_bib39"},{"key":"10.1016\/j.compbiolchem.2025.108740_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108740_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42269-020-00479-6","article-title":"Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak","volume":"45","author":"Shawan","year":"2021","journal-title":"Bull. Natl. Res Cent."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108740_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ptr.7772","article-title":"Multi-target approach against SARS-CoV -2 by stone apple molecules: a master key to drug design","volume":"38","author":"Singh","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.compbiolchem.2025.108740_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104965","article-title":"Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: an in-silico approach","volume":"139","author":"Singh","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiolchem.2025.108740_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104631","article-title":"Identification of potential plant bioactive as SARS-CoV-2 spike protein and human ACE2 fusion inhibitors","volume":"136","author":"Singh","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"8","key":"10.1016\/j.compbiolchem.2025.108740_bib45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cbf.3753","article-title":"Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: a computational insight","volume":"40","author":"Singh","year":"2022","journal-title":"Cell Biochem. amp Funct."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108740_bib46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12038-020-00102-w","article-title":"Identification of a repurposed drug as an inhibitor of spike protein of human coronavirus SARS-CoV-2 by computational methods","volume":"45","author":"Unni","year":"2020","journal-title":"J. Biosci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2025.108740_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/molecules30030491","article-title":"Analysis of structures of SARS-CoV-2 Papain-like protease bound with ligands unveils structural features for inhibiting the enzyme","volume":"30","author":"Varghese","year":"2025","journal-title":"Molecules"},{"issue":"D1","key":"10.1016\/j.compbiolchem.2025.108740_bib48","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: the antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108740_bib49","article-title":"SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: an in silico study","volume":"1","author":"Wong","year":"2021","journal-title":"Phytomed"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125004013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125004013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:30:55Z","timestamp":1765333855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125004013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S1476927125004013"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108740","relation":{},"ISSN":["1476-9271"],"issn-type":[{"type":"print","value":"1476-9271"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative in silico analysis identifies potent natural and synthetic peptide candidates for targeting SARS-CoV-2 viral proteins","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108740"}}